MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2026.1739618

Медицинская библиотека · Frontiers in oncology · 2026

PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells.

Iltzsche Max, Wetterling Nancy, Jilek Lissy, Nahhas Daniel, Hesse Marlena, Tietze Stefanie, Temme Achim, Thomas Christian, Fuessel Susanne, Kind Barbara

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Bladder cancer (BCa), particularly non-muscle invasive bladder cancer (NMIBC), remains a significant healthcare challenge due to high recurrence rates and limited non-surgical treatment options.

METHODS

Prostate stem cell antigen (PSCA)-transduced HEK-BlueTMhTLR9 and PSCA-positive SW780 bladder cancer cells were stimulated with PSCA-targeting NANO:BICs, which were assembled from a scFv(AM1)-KiBAP, NeutrAvidin, and the Toll-like Receptor 9 (TLR9) agonist ODN2006. Functional analyses included a secreted embryonic alkaline phosphatase (SEAP) reporter assay to measure TLR9 activation, a Cytometric Bead Array for cytokine quantification, and confocal microscopy to assess cellular uptake.

RESULTS

PSCA-targeting NANO:BICs demonstrated significantly enhanced uptake into PSCA-positive cancer cells compared to non-targeting controls, with the PSCA receptor increasing uptake by a factor of 3.63. This targeted delivery led to potent activation of the TLR9 signaling pathway, evidenced by a robust reporter gene response and secretion of key antiviral cytokines, including type I and III interferons and the chemokine IP-10.

DISCUSSION: These findings highlight the potential of this approach not only for reinvigorating anti-tumor immune responses in BCa but also for broader applications in other PSCA-expressing malignancies.

Для цитирования: Iltzsche Max, Wetterling Nancy, Jilek Lissy, Nahhas Daniel, Hesse Marlena, Tietze Stefanie, Temme Achim, Thomas Christian, Fuessel Susanne, Kind Barbara. PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells.. Frontiers in oncology. 2026. DOI: 10.3389/fonc.2026.1739618.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.